Lentinula edodes
Botanicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2023 (NCT05763199)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07118735 | N/A | Aug 20, 2025 | National Cheng Kung University |
| NCT06693323 | Phase 2 | Nov 30, 2024 | Chao Family Comprehensive Cancer Center, University of California, Irvine |
| NCT05763199 | Phase 2 | Dec 1, 2023 | Amino Up Chemicals Co., Ltd., National Cancer Institute (NCI), University of California, Davis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amino Up Chemicals Co., Ltd. | For profit | 1 | 0 | 1 | 2023 |
| Chao Family Comprehensive Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2024 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2023 |
| National Cheng Kung University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of California, Irvine | Academic/Hospital | 1 | 1 | 1 | 2024 |
6 organizations
Page 1 / 1